ApconiX Welcomes Dr Kimberly Rockley.

ApconiX Welcomes Dr Kimberly Rockley. ApconiX is delighted to welcome Dr Kimberly Rockley.  Kim has a strong research background in oncology and will work with the team of experts in nonclinical safety and toxicology at ApconiX. Kim studied Biomedical Science and gained her bachelor’s degree and her master’s degree [...]

By |2022-08-17T10:32:58+01:00June 11th, 2019|Toxicology, Careers|Comments Off on ApconiX Welcomes Dr Kimberly Rockley.

ApconiX Joins the MDC’s Virtual R&D platform

ApconiX Joins the MDC’s Virtual R&D platform ApconiX has joined the Medicines Discovery Catapult’s Virtual R&D platform.  This is a unique national network of consultants, private sector CROs, expert labs and public sector centres of excellence, providing medicines discovery expertise, services and virtual programme management. ApconiX specialises in ion [...]

By |2022-02-22T12:48:05+00:00June 6th, 2019|Ion Channels|Comments Off on ApconiX Joins the MDC’s Virtual R&D platform

ApconiX Meet with the Servier Nonclinical Safety Team in Paris

ApconiX Meet with the Servier Nonclinical Safety Team in Paris Professor Ruth Roberts and Dr Paul Duffy recently spent some time with the Servier nonclinical safety team in Paris, hosted by Dr Nancy Claude, Director of Non-Clinical Safety at Servier and Patrick Genissel, Director Centre of Excellence Research & [...]

By |2022-02-22T12:49:24+00:00May 26th, 2019|Toxicology, Events|Comments Off on ApconiX Meet with the Servier Nonclinical Safety Team in Paris

ApconiX Welcomes Dr Russell Huby to the Team.

ApconiX Welcomes Dr Russell Huby to the Team. ApconiX is delighted to welcome Dr Russell Huby to the team.  Russell joins the team of experts in nonclinical safety toxicology at ApconiX and will be primarily working in the area of target safety assessments. Russell graduated from the University of [...]

By |2022-02-22T12:53:49+00:00May 14th, 2019|Target Safety Assessments, Careers|Comments Off on ApconiX Welcomes Dr Russell Huby to the Team.

ApconiX Welcomes Sushma Pabbineedi.

ApconiX Welcomes Sushma Pabbineedi. ApconiX is delighted to welcome Sushma Pabbineedi for a placement during May.  Sushma will be working alongside Dr Michael Morton and Dr Karen Jones in the ion channel laboratory. Sushma studied Biomedical Sciences and gained a bachelor’s degree from Manchester Metropolitan University.  She took a [...]

By |2022-02-22T12:55:17+00:00May 9th, 2019|Ion Channels, Careers|Comments Off on ApconiX Welcomes Sushma Pabbineedi.

Practical Application of Toxicology in Drug Development

Practical Application of Toxicology in Drug Development Professor Ruth Roberts, Co-founder and Director of ApconiX will be joining Rob Wallis and other eminent scientists in delivering training at the highly acclaimed course Practical Application of Toxicology in Drug Development.  The course, co-organised by the British Toxicology Society and the [...]

By |2022-05-12T13:56:45+01:00May 9th, 2019|Events, Toxicology|Comments Off on Practical Application of Toxicology in Drug Development

Professor Ruth Roberts Joins Bio Integrates Panel

Professor Ruth Roberts Joins Bio Integrates Panel Professor Ruth Roberts, Co-founder and Director of ApconiX will join Professor Paul Stott, Chief Executive Officer of Seda Pharmaceutical Development Services, Dr Steve McConchie, Chief Executive Officer of Aptus Clinical and Dr Matt Cooper, Business Development & Marketing Director of National Institute [...]

By |2022-02-22T13:00:05+00:00May 8th, 2019|Toxicology, Events|Comments Off on Professor Ruth Roberts Joins Bio Integrates Panel

Identification of Selective Inhibitors of The Epithelial Sodium Channel ?.

Identification of Selective Inhibitors of The Epithelial Sodium Channel ?. Victoria Miller, a PhD student from the Drug Discovery Centre at the University of Sussex recently spent a few months working in the ApconiX ion channel laboratory as a part of her research. Her PhD project titled “Identification of [...]

By |2022-02-22T13:01:37+00:00May 1st, 2019|Ion Channels, Events|Comments Off on Identification of Selective Inhibitors of The Epithelial Sodium Channel ?.

ApconiX Welcomes Ian Slater to the Team

ApconiX Welcomes Ian Slater to the Team ApconiX is delighted to welcome Ian Slater to the team.  Ian has spent many years in the pharmaceutical industry as a toxicology Study Director and Study Monitor and he joins our nonclinical study monitoring team.  Ian was previously an Associate Principal Toxicologist [...]

By |2022-02-22T13:02:39+00:00April 30th, 2019|Press|Comments Off on ApconiX Welcomes Ian Slater to the Team
Go to Top